Evidence map›Paper›PMID 36934458›Full record

ArticleMolecular genetics & genomic medicine2023

Targeted nanopore sequencing enables complete characterisation of structural deletions initially identified using exon-based short-read sequencing strategies.

Benjamin McClinton, Laura A Crinnion, Martin McKibbin, Rajarshi Mukherjee, James A Poulter, Claire E L Smith, Manir Ali, Christopher M Watson, Chris F Inglehearn, Carmel Toomes

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Long-read sequencing for brain tumors.Frontiers in oncology · 2024
    Review
  9. Applications for Deep Learning in Epilepsy Genetic Research.International journal of molecular sciences · 2023
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Benjamin McClintonLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK.ORCID 0000-0002-8500-0987
Laura A CrinnionLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK.
Martin McKibbinDepartment of Ophthalmology, St James's University Hospital, Leeds, UK.
Rajarshi MukherjeeDepartment of Ophthalmology, St James's University Hospital, Leeds, UK.
James A PoulterLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK.ORCID 0000-0003-2048-5693
Claire E L SmithLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK.ORCID 0000-0001-8320-5105
Manir AliLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK.ORCID 0000-0003-3204-3788
Christopher M WatsonLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK.ORCID 0000-0003-2371-1844
Chris F InglehearnLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK.ORCID 0000-0002-5143-2562
Carmel ToomesLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK.ORCID 0000-0001-8373-9545
University of Leeds · GBSt James's University Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe widespread adoption of exome sequencing has greatly increased the rate of genetic diagnosis for inherited conditions. However, the detection and validation of large deletions remains challenging. While numerous bioinformatics approaches have been developed to detect deletions from whole - exome sequencing and targeted panels, further work is typically required to define the physical breakpoints or integration sites. Accurate characterisation requires either expensive follow - up whole - genome sequencing or the time - consuming, laborious process of PCR walking, both of which are challenging when dealing with the repeat sequences which frequently intersect deletion breakpoints. The aim of this study was to develop a cost-effective, long-range sequencing method to characterise deletions.

methodsGenomic DNA was amplified with primers spanning the deletion using long-range PCR and the products purified. Sequencing was performed on MinION flongle flowcells. The resulting fast5 files were basecalled using Guppy, trimmed using Porechop and aligned using Minimap2. Filtering was performed using NanoFilt. Nanopore sequencing results were verified by Sanger sequencing.

resultsFour cases with deletions detected following comparative read-depth analysis of targeted short-read sequencing were analysed. Nanopore sequencing defined breakpoints at the molecular level in all cases including homozygous breakpoints in EYS, CNGA1 and CNGB1 and a heterozygous deletion in PRPF31. All breakpoints were verified by Sanger sequencing.

conclusionsIn this study, a quick, accurate and cost - effective method is described to characterise deletions identified from exome, and similar data, using nanopore sequencing.

Indexed as

Nanopore SequencingCyclic Nucleotide-Gated Cation ChannelsExomeExonsEye ProteinsHigh-Throughput Nucleotide SequencingHumansWhole Genome SequencingCNGB1 protein, humanCyclic Nucleotide-Gated Cation ChannelsEye ProteinsEYS protein, humanCNGA1CNGB1EYSinherited retinal diseaseNanopore sequencingPRPF31

Identifiers

PMID36934458
PMCPMC10265035
OpenAlexW4327846147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.